US4719205A
(en)
*
|
1984-01-30 |
1988-01-12 |
Wisconsin Alumini Research Foundation |
Side-chain unsaturated 1-hydroxyvitamin D compounds
|
CA1272953A
(fr)
*
|
1984-10-08 |
1990-08-21 |
Yuji Makino |
Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
|
JPS6226223A
(ja)
*
|
1985-07-25 |
1987-02-04 |
Teijin Ltd |
乾癬治療剤
|
US5037816A
(en)
*
|
1984-11-02 |
1991-08-06 |
The General Hospital Corporation |
Method of treating psoriasis
|
US4728643A
(en)
*
|
1984-11-02 |
1988-03-01 |
The General Hospital Corporation |
Method of treating psoriasis
|
JPS6218A
(ja)
*
|
1985-03-14 |
1987-01-06 |
Chugai Pharmaceut Co Ltd |
皮膚疾患治療用組成物
|
EP0227826B1
(fr)
*
|
1985-08-02 |
1989-10-25 |
Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) |
Nouveaux analogues de la vitamine d
|
US5371089A
(en)
*
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
US4897260A
(en)
*
|
1987-05-22 |
1990-01-30 |
The Rockefeller University |
Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
|
US5145846A
(en)
*
|
1988-01-20 |
1992-09-08 |
Hoffmann-La Roche Inc. |
Vitamin D3 analogs
|
US5087619A
(en)
*
|
1988-01-20 |
1992-02-11 |
Hoffman-La Roche Inc. |
Vitamin D3 analogs
|
US4857321A
(en)
*
|
1988-08-26 |
1989-08-15 |
Thomas William C |
Skin ointment
|
EP0385335B1
(fr)
*
|
1989-02-28 |
1995-05-03 |
Nisshin Flour Milling Co., Ltd. |
Compositions stabilisées de vitamines liposolubles
|
US5180747A
(en)
*
|
1989-02-28 |
1993-01-19 |
Nisshin Flour Milling Co., Ltd. |
Stabilized fat-soluble vitamin compositions
|
US5098899A
(en)
*
|
1989-03-06 |
1992-03-24 |
Trustees Of Boston University |
Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
|
US5321018A
(en)
*
|
1989-03-09 |
1994-06-14 |
Wisconsin Alumni Research Foundation |
Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
|
EP0398217B1
(fr)
*
|
1989-05-18 |
1994-01-12 |
F. Hoffmann-La Roche Ag |
Dérivés du déhydrocholécalciférol
|
EP0494224B1
(fr)
*
|
1989-09-25 |
2000-05-10 |
University Of Utah Research Foundation |
Utilisation d'hormones steroides dans des compositions pour induire la production de lymphokine de cellules t
|
EP0494995A4
(en)
*
|
1989-10-04 |
1993-03-17 |
Trustees Of Boston University |
Method of accelerating wound and ulcer healing and treating periodontal disease
|
US5254538A
(en)
*
|
1989-10-04 |
1993-10-19 |
Trustees Of Boston University |
Method of treating periodontal disease
|
GB9004544D0
(en)
*
|
1990-03-01 |
1990-04-25 |
Leo Pharm Prod Ltd |
Novel treatment ii
|
US5276061A
(en)
*
|
1990-08-24 |
1994-01-04 |
Wisconsin Alumni Research Foundation |
Cosmetic compositions containing 1α-hydroxyvitamin D homologs
|
US5366731A
(en)
*
|
1990-08-24 |
1994-11-22 |
Wisconsin Alumni Research Foundation |
Cosmetic compositions containing secosterol compounds
|
AU649057B2
(en)
*
|
1990-08-24 |
1994-05-12 |
Wisconsin Alumni Research Foundation |
Methods and compositions containing vitamin D compounds for improvement of skin conditions
|
US5185150A
(en)
*
|
1990-08-24 |
1993-02-09 |
Wisconsin Alumni Research Fdn. |
Cosmetic compositions containing 19-nor-vitamin D compounds
|
US5459136A
(en)
*
|
1990-08-24 |
1995-10-17 |
Wisconsin Alumni Research Foundation |
Methods using vitamin D compounds for improvement of skin conditions
|
WO1992012165A1
(fr)
*
|
1991-01-08 |
1992-07-23 |
Lunar Corporation |
PROCEDES DE PREPARATION ET UTILISATION DE LA VITAMINE 1α,24-DIHYDROXY D¿2?
|
US20040009958A1
(en)
*
|
1991-01-08 |
2004-01-15 |
Bone Care International, Inc. |
Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
|
GB9109733D0
(en)
*
|
1991-05-07 |
1991-06-26 |
Unilever Plc |
Cosmetic composition
|
US5505948A
(en)
*
|
1993-06-01 |
1996-04-09 |
Dermatology Home Products, Inc. |
Home skin peel composition for producing healthy and attractive skin
|
FR2710841B1
(fr)
*
|
1993-10-05 |
1995-11-17 |
Oreal |
Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
|
EP0704210B1
(fr)
*
|
1994-09-30 |
2002-12-04 |
L'oreal |
Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides
|
EP0711558A1
(fr)
*
|
1994-10-21 |
1996-05-15 |
Unilever Plc |
Des compositions pour application topique sur la peau, les cheveux et les argles
|
US6162801A
(en)
*
|
1995-11-20 |
2000-12-19 |
Kita; Kiyoshi |
External ophthalmic preparation containing vitamin D
|
AU710931B2
(en)
*
|
1996-02-28 |
1999-09-30 |
Sumitomo Pharmaceuticals Company, Limited |
Crystalline vitamin D derivative
|
WO1998053806A1
(fr)
*
|
1997-05-26 |
1998-12-03 |
New Vision Co., Ltd. |
Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k
|
US6187331B1
(en)
|
1997-06-10 |
2001-02-13 |
New Vision Co., Ltd. |
Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D
|
EP2455083B1
(fr)
*
|
1999-04-23 |
2013-09-18 |
Leo Pharma A/S |
Composition pharmaceutique pour application dermique comprenant du calcipotriol et de la bétamethasone pour le traitement du psoriasis
|
US6667045B2
(en)
|
1999-10-01 |
2003-12-23 |
Joseph Scott Dahle |
Topical applications for skin treatment
|
DE10050527A1
(de)
*
|
2000-06-22 |
2002-01-10 |
Willy Ben Moussa |
Verwendung von Glukokortikosteroiden zur Herstellung eines Medikamentes für die Behandlung von Haarschwund
|
AU7250301A
(en)
*
|
2000-06-22 |
2002-01-02 |
Willy Ben Moussa Ben Mohammed |
Use of glucocorticosteroids for producing a medicament to treat oligotrichia
|
PL212660B1
(pl)
*
|
2000-10-27 |
2012-11-30 |
Leo Pharma As |
Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie
|
DE10133198A1
(de)
*
|
2001-07-07 |
2003-01-23 |
Beiersdorf Ag |
Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
|
US20030175314A1
(en)
*
|
2001-11-19 |
2003-09-18 |
Didriksen Erik Johannes |
Pharmaceutical composition for dermal application
|
US20060100181A1
(en)
*
|
2002-05-03 |
2006-05-11 |
Jost-Price Edward R |
Combinations for the treatment of inflammatory skin disorders
|
AU2003291810A1
(en)
*
|
2002-11-18 |
2004-06-15 |
Teva Pharmaceutical Industries Ltd. |
A crystallization method for purification of calcipotriene
|
FR2848454B1
(fr)
*
|
2002-12-17 |
2007-03-30 |
Galderma Res & Dev |
Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
|
PL374777A1
(en)
*
|
2002-12-17 |
2005-10-31 |
Galderma Sa |
Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
|
EP1854466A1
(fr)
*
|
2002-12-17 |
2007-11-14 |
Galderma Research & Development, S.N.C. |
Composition pharmaceutique comprenant du calcitriol et du propionate de clobétasol
|
DE10308852A1
(de)
*
|
2003-02-27 |
2004-09-09 |
Rovi Gmbh & Co. Kosmetische Rohstoffe Kg |
Mittel gegen Faltenbildung der Haut
|
US20040186082A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Hartman Raymond A. |
Enhanced phototherapy for the treatment of cancer and autoimmune disease
|
ATE376834T1
(de)
|
2004-06-17 |
2007-11-15 |
Galderma Sa |
Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
|
FR2871697B1
(fr)
*
|
2004-06-17 |
2007-06-29 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
|
FR2871696B1
(fr)
*
|
2004-06-17 |
2006-11-10 |
Galderma Sa |
Composition topique pour le traitement du psoriasis
|
AU2005253733A1
(en)
*
|
2004-06-17 |
2005-12-29 |
Galderma S.A. |
Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase
|
FR2871699A1
(fr)
*
|
2004-06-17 |
2005-12-23 |
Galderma Sa |
Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
|
FR2871698B1
(fr)
*
|
2004-06-17 |
2008-07-04 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
|
FR2871700B1
(fr)
*
|
2004-06-17 |
2006-11-17 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
|
WO2006133828A1
(fr)
*
|
2005-06-17 |
2006-12-21 |
Dsm Ip Assets B.V. |
Nouvelle utilisation du 25-hydroxycholecalciférol en combinaison avec des agents écrans d’uv-b
|
FR2893847B1
(fr)
*
|
2005-11-30 |
2010-10-29 |
Galderma Sa |
Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
|
AU2007223560A1
(en)
*
|
2006-03-01 |
2007-09-13 |
Tristrata, Inc. |
Composition and method for topical treatment of tar-responsive dermatological disorders
|
MX2009002337A
(es)
*
|
2006-08-29 |
2009-03-20 |
Teva Pharma |
Composiciones farmacologicamente estables que incluyen compuestos que contienen vitamina d y corticosteroides con compatibilidad con bajo ph.
|
EP2070533B1
(fr)
|
2007-12-11 |
2014-05-07 |
Apoteknos Para La Piel, s.l. |
Utilisation d'un composant dérivé de l'acide propionique P-hydroxyphényl pour le traitement de la psoriasis
|
US8968755B2
(en)
|
2010-10-23 |
2015-03-03 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
US8685381B2
(en)
|
2010-10-23 |
2014-04-01 |
Joel Schlessinger |
Topical base and active agent-containing compositions, and methods for improving and treating skin
|
CN103142470B
(zh)
*
|
2013-03-21 |
2014-11-12 |
青岛正大海尔制药有限公司 |
骨化三醇注射液及其制备方法
|
CN103142471B
(zh)
*
|
2013-03-21 |
2014-08-20 |
青岛正大海尔制药有限公司 |
骨化三醇溶液剂及其制备方法
|
CA3051727A1
(fr)
*
|
2017-02-06 |
2018-08-09 |
3Skin As |
Compositions d'ecran solaire transdermique et methodes d'utilisation
|
CN111743906A
(zh)
*
|
2020-04-01 |
2020-10-09 |
南通华山药业有限公司 |
一种阿法骨化醇在制备干预皮肤光损伤外用制剂中的应用
|